Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00416481 · ClinicalTrials.gov registry record
Assessing Older Patients With Cancer
A clinical trial of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 93
- Enrollment target
- 13
- Study locations
NCT00416481: Completed study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Alliance for Clinical Trials in Oncology.
NCT00416481 is a study of Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 93 participants, below the 500-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (81% lower). The trial reports 13 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00416481, a study of Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
- 13
- Study locations
Study Summary
RATIONALE: Questionnaires that measure the ability of older patients to think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer. PURPOSE: This clinical trial is studying ways to assess older patients with cancer.
Conditions Studied
Interventions
- BEHAVIORAL quality of life questionnaires
Study Locations (13)
Indiana
- Elkhart General Hospital - Elkhart
- Howard Community Hospital - Kokomo
- Center for Cancer Therapy at LaPorte Hospital and Health Services - La Porte
- CCOP - Northern Indiana CR Consortium - South Bend
- Memorial Hospital of South Bend - South Bend
- Michiana Hematology-Oncology, PC - South Bend - South Bend
- Saint Joseph Regional Medical Center - South Bend
Nevada
- University Medical Center of Southern Nevada - Las Vegas
- CCOP - Nevada Cancer Research Foundation - Las Vegas
Michigan
- Lakeland Regional Cancer Care Center - St. Joseph - Saint Joseph
New York
- CCOP - Hematology-Oncology Associates of Central New York - East Syracuse
North Carolina
- Duke Comprehensive Cancer Center - Durham
Ohio
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-10 |
What the finished NCT00416481 record still lists
NCT00416481 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 500-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 1 intervention - of which quality of life questionnaires is the first listed.
NCT00416481 lists 13 locations in 6 states (Indiana, Nevada, Michigan).
Frequently Asked Questions
What is clinical trial NCT00416481 about?
NCT00416481 is a clinical study titled "Assessing Older Patients With Cancer". RATIONALE: Questionnaires that measure the ability of older patients to think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer. PURPOSE: This clinical trial is studying ways to assess older patients with cancer.
What is the current status of trial NCT00416481?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2006-12. Estimated completion is 2011-10.
What conditions does trial NCT00416481 study?
This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific.
What interventions are being tested in trial NCT00416481?
The interventions under investigation include: quality of life questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00416481?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00416481 being conducted?
This trial has 13 study locations across Indiana, Michigan, Nevada, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Adult Solid Tumor, Protocol Specific
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00416481's enrollment target sits among peer trials
93 20th of 83 higher than 64 of 83 other Unspecified Adult Solid Tumor, Protocol Specific trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Unspecified Adult Solid Tumor, Protocol Specific trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
RECRUITING
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
RECRUITING
-
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
RECRUITING
-
Registry of Older Patients With Cancer
RECRUITING
-
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RECRUITING
-
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia